The clinical Spectrum of Viridans Group Streptococci infections in paediatric patients at a tertiary hospital

被引:0
|
作者
Shongwe, Nkosinathi S. [1 ]
Mabena, Fikile C. [1 ,2 ]
Wadula, Jeannette [3 ,4 ]
Petersen, Karen [1 ,2 ]
机构
[1] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat & Child Hlth, Johannesburg, South Africa
[2] Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Johannesburg, South Africa
[3] Univ Witwatersrand, Fac Hlth Sci, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa
[4] Chris Hani Baragwanath Acad Hosp, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa
关键词
Viridans Group Streptococcus; antibiotics; susceptibility; clinical presentation; organism; ANTIMICROBIAL SUSCEPTIBILITY; BACTEREMIA; RESISTANCE; CHILDREN; SEPSIS; COUNT;
D O I
10.4102/sajid.v39i1.563
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Viridans Group Streptococci (VGS) are often considered organisms of low virulence; however, infection can result in clinically significant sepsis and life-threatening complications in paediatric patients. Objectives: This study aimed to describe the spectrum of clinical presentation of VGS bacteraemia in paediatric patients, to analyse risk factors, and to describe the antibiotics resistance patterns of VGS. Method: Cultures of VGS in paediatric patients admitted to Chris Hani Baragwanath Academic Hospital in 2019 were identified through National Health Laboratory Service. Data were extracted from archived clinical records and analysed. Sepsis scores were calculated at the time of bacteraemia. Results: A total of 133 cultures were identified; 64 (48.1 % ) polymicrobial cultures and no records 4 (0.03 % ) were excluded; 65 (48.9 % ) were analysed. The median age was 1.5 months (range 0.03 to 168, interquartile range [IQR]: 0.3-13.25), 27/65 (42 % ) were neonates. The median duration of hospitalisation was 7 days (IQR: 3-21). The commonest diagnoses were neonatal sepsis 30.8 % ( n = 20) and pneumonia 28 % ( n = 18). The systemic inflammatory response syndrome (SIRS) score was >= 2 in 57 % (16/28) patients; paediatric sequential organ failure assessment (pSOFA) score was > 2 in 10/24 (42 % ). Fifty-seven (88 % ) patients were discharged; three (5 % ) required ICU admission and 8/65 (12.3 % ) died. Malnutrition was present in 50 % of patients who died. Cephalosporins and penicillin had sensitivity of 89 % and 55 %, respectively. Conclusion: Viridans Group Streptococci bacteraemia was common in neonates, and pneumonia was a common presentation in this cohort. The VGS bacteraemia was associated with morbidity and deaths in this cohort. Contribution: The VGS should be considered a significant organism when cultured from sterile sites and routine antibiotic susceptibility testing should be performed. Prospective studies are recommended.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] THE CLINICAL SPECTRUM OF INFECTIONS WITH VIRIDANS STREPTOCOCCI IN BONE-MARROW TRANSPLANT PATIENTS
    VILLABLANCA, JG
    STEINER, M
    KERSEY, J
    RAMSAY, NKC
    FERRIERI, P
    HAAKE, R
    WEISDORF, D
    BONE MARROW TRANSPLANTATION, 1990, 5 (06) : 387 - 393
  • [2] Clinical features of district hospital paediatric patients with pharyngeal group A streptococci
    Hossain, P
    Kostiala, A
    Lyytikäinen, O
    Kurki, S
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2003, 35 (01) : 77 - 79
  • [3] Infections with viridans group streptococci in children with cancer
    Reilly, Anne F.
    Lange, Beverly J.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (06) : 774 - 780
  • [4] Microbiology and clinical characteristics of viridans group streptococci in patients with cancer
    Guerrero-Del-Cueto, Fuensanta
    Ibanes-Gutierrez, Cyntia
    Velazquez-Acosta, Consuelo
    Cornejo-Juarez, Patricia
    Vilar-Compte, Diana
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2018, 22 (04): : 323 - 327
  • [5] Infections caused by viridans streptococci in patients with neutropenia
    Tunkel, AR
    Sepkowitz, KA
    CLINICAL INFECTIOUS DISEASES, 2002, 34 (11) : 1524 - 1529
  • [6] Group Milleri Streptococci in Paediatric Infections
    Stelzmueller, I.
    Fille, M.
    Hager, J.
    Dossett, L.
    Sifri, C. D.
    Bonatti, H.
    EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 2009, 19 (01) : 21 - 24
  • [7] Antimicrobial susceptibility patterns and macrolide resistance genes of β-hemolytic viridans group streptococci in a tertiary Korean hospital
    Uh, Young
    Hwang, Gyu Yel
    Jang, In Ho
    Kwon, Ohgun
    Kim, Hyo Youl
    Yoon, Kap Jun
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (05) : 791 - 794
  • [8] Infections due to group C beta-hemolytic streptococci in a tertiary hospital
    Martín, L
    Murillas, J
    de Gopegui, ER
    Villalonga, C
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2004, 22 (05): : 308 - 309
  • [9] VIRIDANS GROUP STREPTOCOCCAL INFECTIONS IN CHILDREN FOLLOWING CHEMOTHERAPY OR STEM CELL TRANSPLANTATION-A TEN YEAR RETROSPECTIVE REVIEW FROM A TERTIARY PAEDIATRIC HOSPITAL
    Nielsen, M. J.
    Claxton, S.
    Pizer, B.
    Cooke, R. P. D.
    Paulus, S.
    Carrol, E.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S387 - S388
  • [10] Identification and characterization of catheter-related bloodstream infections due to viridans group streptococci in patients with cancer
    Shelburne, Samuel A., III
    Chaftari, Anne-Marie
    Jamal, Mohamed
    Al Wohoush, Iba
    Jiang, Ying
    Abughazaleh, Shaadi
    Cairo, Javier
    Raad, Sammy
    Debiane, Labib
    Raad, Issam
    AMERICAN JOURNAL OF INFECTION CONTROL, 2014, 42 (10) : 1127 - 1129